Realtime | Geld | Brief | Zeit |
---|---|---|---|
4,290 | 4,315 | 17:26 | |
4,280 | 4,315 | 17:23 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.05. | ONWARD Medical NV: ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants | 431 | GlobeNewswire (Europe) | Groundbreaking procedures extend ONWARD's leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury... ► Artikel lesen | |
30.04. | ONWARD Medical NV: ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions | 566 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies... ► Artikel lesen | |
ONWARD MEDICAL Aktie jetzt für 0€ handeln | |||||
28.04. | ONWARD Medical NV: ONWARD Medical Announces Release of 2024 Annual Report | 370 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, April 28, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
24.04. | ONWARD Medical NV: ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market | 355 | GlobeNewswire (Europe) | Sponsored Level 1 ADR program facilitates trading by US investors following recent FDA clearance and commercial launch
BNY will be ADR depositary bank
Ticker symbol for US investors is ONWRY
EINDHOVEN... ► Artikel lesen | |
23.04. | OTC Markets Group Welcomes ONWARD Medical N.V. to OTCQX | 197 | GlobeNewswire (Europe) | NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ONWARD Medical... ► Artikel lesen | |
01.04. | ONWARD Medical NV: ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights | 507 | GlobeNewswire (Europe) | Received FDA authorization and recorded first commercial sales of ARC-EX System
Secured strategic investment from Ottobock and extended cash runway for two years
Gained exclusive rights to premier... ► Artikel lesen | |
26.03. | ONWARD Medical NV: ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility | 384 | GlobeNewswire (Europe) | The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study
The Company is building a portfolio of purpose-designed leads to optimize delivery... ► Artikel lesen | |
19.03. | ONWARD Medical NV: ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast | 476 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
04.03. | ONWARD Medical NV: ONWARD Medical to Advance Parkinson's Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense | 831 | GlobeNewswire (Europe) | The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's disease; the first participant was enrolled in late 2024
A US Department... ► Artikel lesen | |
25.02. | ONWARD Medical NV: ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy | 442 | GlobeNewswire (Europe) | Study shows significant functional improvements after one year of ARC-EX Therapy
Improvements were observed throughout one-year treatment period with no plateau
Results demonstrate the importance... ► Artikel lesen | |
29.01. | ONWARD Medical NV: ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms | 500 | GlobeNewswire (Europe) | ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms
Partnership with Lovell Government Services is providing... ► Artikel lesen | |
13.01. | ONWARD Medical NV: ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference | 509 | GlobeNewswire (Europe) | CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025EINDHOVEN, the Netherlands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company... ► Artikel lesen | |
09.01. | ONWARD Medical NV: ONWARD Medical Announces First Commercial Sales of ARC-EX System | 678 | GlobeNewswire (Europe) | UW Medicine and Next Steps Chicago both purchased systems in late December 2024
ARC-EX is the first and only FDA approved technology indicated to improve hand strength and sensation in people with... ► Artikel lesen | |
19.12.24 | ONWARD Medical NV: ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World's First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury | 599 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
ARC-EX System is the first and only FDA approved technology... ► Artikel lesen | |
12.12.24 | ONWARD Medical NV: ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability | 822 | GlobeNewswire (Europe) | EcoVadis silver medal recognizes Company's environmental and social impact
Demonstrates ongoing commitment to integrating sustainable business practices
EINDHOVEN, the Netherlands, Dec. 12,... ► Artikel lesen | |
26.11.24 | ONWARD Medical NV: ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights | 546 | GlobeNewswire (Europe) | Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor
Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer... ► Artikel lesen | |
19.11.24 | ONWARD Medical NV: ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke | 560 | GlobeNewswire (Europe) | Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke
Funding... ► Artikel lesen | |
12.11.24 | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights | 593 | GlobeNewswire (Europe) | Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE... ► Artikel lesen | |
31.10.24 | ONWARD Medical NV: ONWARD ARC-EX System Named One of TIME's Best Inventions of 2024 | 550 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence... ► Artikel lesen | |
28.10.24 | ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering | 598 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, Oct. 28, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 44,300 | +0,14 % | DAX-Check LIVE: Douglas, Evotec, Fresenius, Merck, Renk, SAP im Fokus | Der DAX konnte seine anfänglichen Gewinne am Donnerstag nicht halten und rutschte im Tagesverlauf ins Minus. Er schloss 0,44 Prozent tiefer und entfernte sich damit weiter von seinem Rekordhoch bei... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 50,26 | -0,51 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC von 37 auf 40 Euro angehoben, aber die Einstufung auf "Underperform" belassen. Zwar habe er seine Gewinnerwartungen infolge... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,640 | +0,24 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
CARL ZEISS MEDITEC | 59,85 | +1,01 % | Carl Zeiss Meditec - Günstig bewertet; Foerst muss es jetzt richten | In den beiden ersten Teilen unserer Serie zu Carl Zeiss Meditec haben wir die jüngsten Führungswechsel und die kurzzeitigen Hemmnisse im Geschäftsmodell beleuchtet. Im dritten Teil prüfen wir, ob die... ► Artikel lesen | |
ECKERT & ZIEGLER | 64,95 | -3,64 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum
30.05.2025 / 10:00 CET/CEST
Für... ► Artikel lesen | |
DRAEGERWERK | 72,00 | +2,71 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 der Kommission | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1... ► Artikel lesen | |
MEDTRONIC | 76,55 | +0,63 % | Medtronic plc-Aktie mit leichten Kursgewinnen (75,8105 €) | Im Wertpapierhandel liegt die Aktie von Medtronic plc aktuell im Plus. Das Wertpapier notiert zur Stunde bei 86,75 US-Dollar. Die Aktie von Medtronic plc verzeichnet gegenwärtig ein Kursplus von 1,34... ► Artikel lesen | |
INTUITIVE SURGICAL | 492,25 | +0,86 % | What Makes Intuitive Surgical (ISRG) an Investment Bet? | ||
UNITEDHEALTH | 262,75 | +1,59 % | Trump macht China Vorwürfe - Nvidia, Disney, UnitedHealth, Constellation Energy, GE Vernova & Co | Die US-Börsen zeigten sich am Donnerstag freundlich. Der Dow Jones schloss mit einem Anstieg von 0,28%. Zunächst sorgte ein Rückschlag für Trumps aggressive Zollpolitik für positive Stimmung. Diese... ► Artikel lesen | |
GERRESHEIMER | 47,800 | -2,73 % | Allianz, Amazon, Deutsche Konsum, Gerresheimer, Hensoldt, Moderna - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
TELADOC HEALTH | 6,348 | +4,86 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June... ► Artikel lesen | |
THERMO FISHER | 356,75 | +2,44 % | Traders Eye a Breakout in Thermo Fisher Scientific (TMO) Amid Market Undercurrents | ||
RHOEN-KLINIKUM | 12,900 | 0,00 % | Dividendenbekanntmachungen (04.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADESSO SE DE000A0Z23Q5 - 0,75 EUR AGEAS SA/NV BE0974264930 - 2 EUR AIR LEASE CORPORATION US00912X3026 0,22 USD 0,1934 EUR ANALOG... ► Artikel lesen | |
BIOTEST | 28,400 | -3,40 % | EQS-Adhoc: Biotest AG: Delisting der Biotest-Aktien von der Frankfurter Wertpapierbörse mit Ablauf des 6. Juni 2025 | EQS-Ad-hoc: Biotest AG / Schlagwort(e): Delisting
Biotest AG: Delisting der Biotest-Aktien von der Frankfurter Wertpapierbörse mit Ablauf des 6. Juni 2025
03.06.2025 / 16:51 CET/CEST
Veröffentlichung... ► Artikel lesen | |
ROKU | 66,50 | +1,90 % | Roku Stock Is Beaten Down Now, but It Could 10X |